-
-
-
-
-
-
-
Zoetis (ZTS) Declares $0.53 Quarterly Dividend; 1.7% Yield
-
-
-
-
-
-
-
KeyBanc Starts Zoetis Inc. (ZTS) at Sector Weight
-
-
-
-
-
-
-
Zoetis receives Health Canada approval for dog arthritis pain therapy
-
-
-
-
-
-
-
Zoetis Inc. (ZTS) PT Lowered to $165 at UBS
-
-
-
-
-
-
-
Zoetis (ZTS): Dr. Mark Stetter Elected to Zoetis Board of Directors
-
-
-
-
-
-
-
Firms face COVID-level uncertainty amid Trump tariffs - Morgan Stanley
-
-
-
-
-
-
-
Zoetis (ZTS) Announces U.S. Label Update for Librela, a Treatment to Control Canine Osteoarthritis (OA) Pain
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

